Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-C956050-1G 1 g
Alpha-Cyano-Alpha,Beta-diethylvaleric Acid Ethyl Ester
Sign In for Pricing
View Details MBS9919290-01 48 Well
Rat Small Proline-Rich Protein 2A (SPRR2A) ELISA Kit
Sign In for Pricing
View Details MBS9919290-02 96 Well
Rat Small Proline-Rich Protein 2A (SPRR2A) ELISA Kit
Sign In for Pricing
View Details